• 06/18/2018 Consolidated Financial Results for the Fiscal Year Ended March 31, 2018 (IFRS) （131KB）

• 06/18/2018 Etanercept BS Licensing Agreement （130KB）

• 05/29/2018 Notice of the 54th Ordinary General Meeting of Shareholders （206KB）

• 05/14/2018 FY2017 ended March 2018, Presentation （2,288KB）

• 05/14/2018 Year Ending March 31, 2018 Results Settlement of Accounts Supplementary Material (Apr.1 to Mar.31 2018) （1,189KB）

全てのニュース